Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials

John B. Buse, David C. Klonoff, Loretta L. Nielsen, Xuesong Guan, Christopher Bowlus, John H. Holcombe, David G. Maggs, Matthew E. Wintle

Research output: Contribution to journalArticlepeer-review

239 Scopus citations

Fingerprint

Dive into the research topics of 'Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials'. Together they form a unique fingerprint.

Medicine & Life Sciences